FDA Drug Recalls

Recalls / Class II

Class IID-231-2013

Product

NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM. DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong.

Affected lot / code info
Lot HJLA,

Why it was recalled

Marketed Without an Approved NDA/ANDA: The products are unapproved drugs

Recalling firm

Firm
Palmer Natural Products
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
11665 W State St, N/A, Star, Idaho 83669-5223

Distribution

Quantity
672 bottles
Distribution pattern
Florida, Idaho, California and Hong Kong. This product can be ordered on line.

Timeline

Recall initiated
2013-03-11
FDA classified
2013-04-01
Posted by FDA
2013-04-10
Terminated
2013-08-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-231-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls